Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development
Zev A. Binder, Amy Haseley Thorne, Spyridon Bakas, et al.
Cancer Cell (2018) Vol. 34, Iss. 1, pp. 163-177.e7
Open Access | Times Cited: 147

Showing 26-50 of 147 citing articles:

Current Advances and Challenges in Radiomics of Brain Tumors
Zhenjie Yi, Lifu Long, Yu Zeng, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 40
GaNDLF: the generally nuanced deep learning framework for scalable end-to-end clinical workflows
Sarthak Pati, Siddhesh Thakur, İbrahim Ethem Hamamcı, et al.
Communications Engineering (2023) Vol. 2, Iss. 1
Open Access | Times Cited: 18
Radiomics and Machine Learning in Brain Tumors and Their Habitat: A Systematic Review
Mehnaz Tabassum, Abdulla Al Suman, Eric Suero Molina, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3845-3845
Open Access | Times Cited: 17
Development and multicenter validation of a novel radiomics-based model for identifying eosinophilic chronic rhinosinusitis with nasal polyps
K-Z. Zhu, Cong He, Zhonghai Li, et al.
Rhinology Journal (2023)
Open Access | Times Cited: 16
Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma
Binghao Zhao, Jia‐Ming Wu, Huanzhang Li, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma
Zuoxin Zhang, Zengguang Wang, Kai Huang, et al.
Cancer Letters (2018) Vol. 443, pp. 91-107
Closed Access | Times Cited: 50
Oncogenic mutations at the EGFR ectodomain structurally converge to remove a steric hindrance on a kinase-coupled cryptic epitope
Laura Orellana, Amy Haseley Thorne, Rafael Lema, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 20, pp. 10009-10018
Open Access | Times Cited: 49
Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR -mutant glioblastoma
Igor Makhlin, Ryan Salinas, Daniel Zhang, et al.
CNS Oncology (2019) Vol. 8, Iss. 3
Open Access | Times Cited: 43
Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route
Natália Noronha Ferreira, Sara Granja, Fernanda Guarilha Boni, et al.
Drug Delivery and Translational Research (2020) Vol. 10, Iss. 6, pp. 1729-1747
Closed Access | Times Cited: 43
Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment
Soma Ghosh, Ilaria Marrocco, Yosef Yarden
Advances in cancer research (2020), pp. 1-57
Closed Access | Times Cited: 42
Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non–small-cell lung cancer: a multicenter study using targeted next-generation sequencing
Yen‐Ting Lin, Chi‐Lu Chiang, Jen‐Yu Hung, et al.
European Journal of Cancer (2021) Vol. 156, pp. 1-11
Open Access | Times Cited: 31
EGFR, the Lazarus target for precision oncology in glioblastoma
Benjamin Lin, Julia Ziebro, Erin Smithberger, et al.
Neuro-Oncology (2022) Vol. 24, Iss. 12, pp. 2035-2062
Open Access | Times Cited: 24
Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy
Justyna Mączyńska, Florian Raes, Chiara Da Pieve, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 22
Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures
Leland Hu, Fulvio D’Angelo, Taylor M. Weiskittel, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Image-based Classification of Tumor Type and Growth Rate using Machine Learning: a preclinical study
Tien T. Tang, Janice A. Zawaski, Kathleen N. Francis, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 41
A network pharmacology-based study on the anti-hepatoma effect of Radix Salviae Miltiorrhizae
Yi Luo, Yu Feng, Lei Song, et al.
Chinese Medicine (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 39
Precision diagnostics based on machine learning-derived imaging signatures
Christos Davatzikos, Aristeidis Sotiras, Yong Fan, et al.
Magnetic Resonance Imaging (2019) Vol. 64, pp. 49-61
Open Access | Times Cited: 37
Analyzing magnetic resonance imaging data from glioma patients using deep learning
Bjoern Menze, Fabian Isensee, Roland Wiest, et al.
Computerized Medical Imaging and Graphics (2020) Vol. 88, pp. 101828-101828
Open Access | Times Cited: 36
Cancer Imaging Phenomics via CaPTk: Multi-Institutional Prediction of Progression-Free Survival and Pattern of Recurrence in Glioblastoma
Anahita Fathi Kazerooni, Hamed Akbari, Garima Shukla, et al.
JCO Clinical Cancer Informatics (2020), Iss. 4, pp. 234-244
Open Access | Times Cited: 34
A novel strategy for glioblastoma treatment combining alpha-cyano-4-hydroxycinnamic acid with cetuximab using nanotechnology-based delivery systems
Natália Noronha Ferreira, Sara Granja, Fernanda Guarilha Boni, et al.
Drug Delivery and Translational Research (2020) Vol. 10, Iss. 3, pp. 594-609
Closed Access | Times Cited: 32
High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms
Radhika Thokala, Zev A. Binder, Yibo Yin, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 26
Comprehensive Analyses of Ferroptosis-Related Alterations and Their Prognostic Significance in Glioblastoma
Yuan Tian, Hongtao Liu, Caiqing Zhang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 19
The federated tumor segmentation (FeTS) tool: an open-source solution to further solid tumor research
Sarthak Pati, Ujjwal Baid, Brandon Edwards, et al.
Physics in Medicine and Biology (2022) Vol. 67, Iss. 20, pp. 204002-204002
Open Access | Times Cited: 19
Identification of dual-purpose therapeutic targets implicated in aging and glioblastoma multiforme using PandaOmics - an AI-enabled biological target discovery platform
Andrea Olsen, Zachary Harpaz, Christopher X. Ren, et al.
Aging (2023)
Open Access | Times Cited: 11
ARL3 is downregulated and acts as a prognostic biomarker in glioma
Yulin Wang, Weijiang Zhao, Xin Liu, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 34

Scroll to top